Publication | Closed Access

Blockade of endothelin receptor A enhances the therapeutic efficacy of gemcitabine in pancreatic cancer cells

Pancreatic CancerMedicineEndothelin Receptor APancreatic Cancer CellsTherapeutic EfficacyAnti-cancer AgentPharmacologyCell Biology